A member of the B cell signaling pathway triggered upon B cell activation (TNFRSF17, a receptor for BLyS-BAFF) was identified as a key predictive factor for neutralizing antibody response to yellow fever vaccination (24). Here, TNFRSF17 is linked to viral infectious disease.